EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of adjuvant Endoxan therapy in curative resected patients with stomach cancer


Nihon Gan Chiryo Gakkai Shi 20(1): 114-121
Evaluation of adjuvant Endoxan therapy in curative resected patients with stomach cancer
The effect of Endoxan (EX) therapy was evaluated and its interaction with some prognostic factors, based on the data of 213 stomach cancer patients with curative resection who were followed up in Kagawa Prefectural Central Hospital [Japan]. Those patients accounted for 30% of Stomach Cancer Postoperative Study Group1. The profiles were examined of the patients for whom the EX therapy was particularly effective. As a consequence, serosal invasion(s) and lymph node involvement(n) were emerged as the most influential factors on the prognosis and the EX therapy was effective for patients with symptoms s(-)n(-) and s(+)n(+). In other words, further short-term adjuvant therapy was particularly effective for s(-)n(-) whereas long-term one was effective for s(+)n(+).


Accession: 005395956

PMID: 3998566



Related references

Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer. Thoracic Cancer 5(1): 50-56, 2014

Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer. Thoracic Cancer 5(1): 50-56, 2013

Evaluation of liaison-clinical pathway for patients with breast cancer undergoing adjuvant therapy after curative operation--data from questionnaire survey of 56 clinics and 105 patients. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 37(8): 1477-1481, 2010

Administration and dosage of fluorouracil (5-FU) continuous i.v. infusion in patients with non-curative resected/non-resected gastric cancer. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 23(5): 567-572, 1996

A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer. Gynecologic Oncology 128(1): 65-70, 2013

Cancer chemo therapy by simultaneous administration of thio inosine 5 fluoro uracil endoxan and mitomycin c as an adjuvant therapy of radio therapy. Japan Society For Cancer Therapy The Journal Of Japan Society For Cancer Therapy English Abstracts Of Proceeding Of The Eighth Congress Of The Japan Society For Cancer Therapy Osaka Oct 19, 20, 117 P Japan Society For Cancer Therapy: Department Of Surgery, School Of Medicine, Kyoto University, Sakyoku, Kyoto, Japan 77-79, 1970

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study. Bmc Cancer 9(): 345-345, 2010

Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. Journal of Clinical Oncology 19(6): 1879-1880, 2001

Adjuvant therapy in patients with resected poor-risk head and neck cancer. Journal of Clinical Oncology 24(17): 2629-2635, 2006

Adjuvant sorafenib therapy in patients with resected hepatocellular carcinoma: evaluation of predictive factors. Medical Oncology 32(4): 107-107, 2016